About: CNS penetration of potential anti-COVID-19 drugs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: CNS penetration of potential anti-COVID-19 drugs Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	CNS penetration of potential anti-COVID-19 drugs
Creator	Corbellino, Mario Richardson, Peter Stebbing, Justin Casalini, Giacomo Ottaviani, Silvia Prelle, Alessandro
source	Medline; PMC
abstract	covid:f4d7b8628515eab724e7835af265c2868aeaf691#abstract
has issue date	2020-05-02(xsd:dateTime)
bibo:doi	10.1007/s00415-020-09866-5
bibo:pmid	32361836
has license	cc-by
sha1sum (hex)	f4d7b8628515eab724e7835af265c2868aeaf691
schema:url	https://doi.org/10.1007/s00415-020-09866-5
resource representing a document's title	CNS penetration of potential anti-COVID-19 drugs
has PubMed Central identifier	PMC7195609
has PubMed identifier	32361836
schema:publication	J Neurol
resource representing a document's body	covid:f4d7b8628515eab724e7835af265c2868aeaf691#body_text
is schema:about of	named entity 'CNS' named entity 'SARS virus' named entity 'peptidase' named entity 'MERS' named entity 'SARS-CoV-2' named entity 'endothelial cells' named entity 'genetic material' named entity 'CSF' named entity 'autopsy' named entity 'Baricitinib' named entity 'visual hallucinations' named entity 'nasopharyngeal swab' named entity 'Open Access' named entity 'clinical trials' named entity 'blood brain barrier' named entity 'neurological damage' named entity 'ruxolitinib' named entity 'antibiotic' named entity 'consciousness' named entity 'antibody' named entity 'brain tissue' named entity 'fever' named entity 'olfactory nerve' named entity 'peripherally' named entity 'mice' named entity 'COVID-19' named entity 'penetrance' named entity 'hallucinations' named entity 'Creative Commons licence' named entity 'dizziness' named entity 'clinical trials' named entity 'IL-6' named entity 'ACE2' named entity 'SARS' named entity 'penetrance' named entity 'anti-inflammatory effect' named entity 'penetrance' named entity 'dysexecutive syndrome' named entity 'lopinavir/ritonavir' named entity 'CNS' named entity 'virus' named entity 'encephalitis' named entity 'baricitinib' named entity 'neurological' named entity 'CSF' named entity 'virus' named entity 'remdesivir' named entity 'epilepsy' named entity 'baricitinib' named entity 'hydroxychloroquine' named entity 'ataxia' named entity 'randomised clinical trials' named entity 'headache' named entity 'neurocognitive deficits' named entity 'IL6R' named entity 'anti-inflammatory' named entity 'clinical trials' named entity 'SARS-CoV-2' named entity 'Creative Commons Attribution 4.0' named entity 'SARS-CoV-2' named entity 'infection' named entity 'SARS' named entity 'blood brain barrier' named entity 'COVID-19 pandemic' named entity 'infection' named entity 'receptor' named entity 'virus' named entity 'baricitinib' named entity 'CNS' named entity 'Creative Commons licence' named entity 'Strasbourg' named entity 'cerebrovascular disease' named entity 'SARS-CoV-2' named entity 'mice' named entity 'Tocilizumab' named entity 'anti-malarial'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software